Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00452842 · ClinicalTrials.gov registry record
Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies
A clinical trial, sponsored by Pfizer.
- Terminated
- Registry status
- 26,784
- Enrollment target
NCT00452842 is a clinical trial that was terminated before completion, run by Pfizer. The registered enrollment target is 26,784 participants.
The verdict
NCT00452842 was terminated before completion, sponsored by Pfizer.
- TERMINATED
- Registry status
- 26,784 participants
- Enrollment target
Study Summary
An observational safety follow up trial will be conducted to monitor the occurrence of cardiovascular events and all cause mortality in subjects who participated in selected torcetrapib/atorvastatin Phase 1, 2, and 3 clinical trials. No hypotheses will be tested.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26,784 participants |
| Start Date | 2007-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00452842
The ClinicalTrials.gov registry entry for NCT00452842 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 26,784 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00452842 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00452842 about?
NCT00452842 is a clinical study titled "Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies". An observational safety follow up trial will be conducted to monitor the occurrence of cardiovascular events and all cause mortality in subjects who participated in selected torcetrapib/atorvastatin Phase 1, 2, and 3 clinical trials. No hypotheses will be tested.
What is the current status of trial NCT00452842?
This trial is currently terminated. The enrollment target is 26,784 participants. The study started on 2007-10.
Who is sponsoring clinical trial NCT00452842?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.